NCT05266001: An ongoing trial by Nationwide Children's Hospital
This trial is ongoing. It must report results 8 months from now.
Full data
Full entry on ClinicalTrials.gov | NCT05266001 |
---|---|
Title | GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS |
Results Status | Ongoing |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | June 14, 2022 |
Completion date | Dec. 1, 2024 |
Required reporting date | Dec. 1, 2025, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | March 28, 2025 |
Days late | None |